Educational content series — neutral, no vendor promotion. Written without em dashes. T-Breaks: The Science of Resetting Your Tolerance The Reset Button Your Brain Is Waiting For Every heavy cannabis user knows the feeling. The high that once arrived in five minutes and lasted three hours now takes twenty minutes and fades by the end […]
Category Archives: Articles
The Other Prescription Crisis The opioid crisis gets the headlines, for reasons that are tragically understandable. But running quietly alongside it, through the same pharmacies and the same medicine cabinets, is a second prescription-drug catastrophe that receives a fraction of the attention: benzodiazepines. Xanax, Ativan, Klonopin, Valium, and their siblings are among the most prescribed […]
A Tree, a Tea, and an Identity Crisis Mitragyna speciosa is a tree in the coffee family, native to Southeast Asia, where its leaves have been chewed and brewed by laborers for centuries: a stimulant in small amounts, a sedative in large ones, a folk remedy for pain and fatigue, and a component of regional […]
The Product That Ate the Tobacco Market In the span of barely a decade, the nicotine landscape transformed. Cigarette smoking among young people, declining for forty years, suddenly faced a new delivery device that was discrete, flavored, cheap, and engineered with consumer-electronics sophistication. Disposable vapes, led by the nicotine-salt pod systems that deliver cigarette-like nicotine […]
The Delivery Question Cannabis consumers face a decision that cigarette smokers made decades ago, with less data and more confusion: how to get the molecule without the smoke. Combustion is the shared enemy in both cases. Burning plant material of any kind produces tar, carbon monoxide, and a suite of respiratory irritants and carcinogens, and […]
The Generation That Never Stopped Being Curious The stereotype of the psychedelic user is twenty-two, but the fastest-growing curiosity in the field belongs to people in their sixties, seventies, and eighties. Older adults are arriving at psychedelic exploration through several doors at once: the clinical trial pipeline, which is now studying depression and existential distress […]
The Forgetful Stoner Is a Pharmacological Fact The stereotype exists for a reason. The misplaced keys, the looped conversation, the sentence that dissolves mid-clause, the errand that vanishes between the couch and the car: acute cannabis use impairs memory in specific, well-mapped ways, and every regular user has met the phenomenon personally. But the stereotype […]
The Industry Nobody Regulates The retreat industry is the growth story of the psychedelic era: hundreds of centers operating in Peru, Costa Rica, Mexico, Brazil, Jamaica, the Netherlands, Portugal, and a lengthening list of jurisdictions where legal frameworks, traditional lineages, or simple enforcement tolerance allow commercial ceremony. They range from serious Amazonian lineages with decades […]
The Population That Never Stopped Advocating If you want to understand why psychedelic policy moved as fast as it did in the United States, follow the veterans. Military veterans with post-traumatic stress disorder became the most politically effective constituency in the entire renaissance: a population of undoubted sacrifice and public sympathy, carrying a condition that […]
Older Than the Word "Drug" Long before the word "psychedelic" existed, before Hofmann's bicycle and Shulgin's notebooks and the clinical trial, humans were in relationship with the visionary plants. Archaeological evidence places psychoactive plant use deep in prehistory: the Selva Pascuala mural in Spain suggests psilocybin mushroom ritual eleven thousand years ago; the ceremonial paraphernalia […]